Pathology of lung cancer.

By W. Travis. Clinics in Chest Medicine, 2002

633 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/1f8fb05273fd8131d53e0ee3ee657c9b79621636

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. William Pao
2. P. Jänne
3. Vincent A. Miller
4. Gad Getz
5. Eric S. Lander
6. Jin-Yuan Shih
7. Shang-Gin Wu
8. J. Engelman

In Pulmonary and Respiratory Medicine

1. William Pao
2. P. Jänne
3. Vincent A. Miller
4. Charles A. Powell
5. Juan Wisnivesky
6. J. Barta
7. Jin-Yuan Shih
8. Shang-Gin Wu

Citations in the corpus

• Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer (2015, neutral): “Decreased appetite 14 (11) 1 (1) 25 (19) 1 (1)”
• Global Epidemiology of Lung Cancer (2019, background): “Historically, squamous cell lung cancer occurred more commonly as central lesions, but peripheral tumors are rising in incidence [41].”
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing (2012, background): “Lung cancer is a leading cause of death worldwide, resulting in more than 1.3 million deaths per year, of which more than 40% are lung adenocarcinomas (World Health Organization, 2012; Travis, 2002).”